Pfizer Taps Into 'Doggybone DNA' For mRNA Vaccines, Gene Therapy Production
Targets Manufacturing Bottleneck
The deal allows Pfizer to manufacture 'doggybone DNA' in its own facilities, but further details have not been disclosed. • Source: Shutterstock 
